Medication Safety in Pediatric Inpatients
Conditions
Brief summary
The goal of this study is to learn whether a clinical pharmacist-led medication review, supported by medical mobile applications, can improve the safety and quality of care for hospitalized children. The study compares usual care with enhanced pharmacist involvement to understand whether this approach reduces medication-related problems and supports better clinical outcomes. The main questions this study aims to answer are: Does the pharmacist-led review help identify and prevent medication issues in pediatric inpatients? Can this intervention improve the overall quality of care during hospitalization? Does the use of mobile medical applications assist pharmacists in making safer medication decisions? Participants will: Receive either routine care or routine care plus daily medication review by a clinical pharmacist Have their medications assessed regularly to identify potential problems Be followed during their hospital stay to observe clinical outcomes
Interventions
Daily medication review conducted by a clinical pharmacist using mobile medical applications to identify potential medication-related problems and support safer prescribing decisions for hospitalized pediatric patients.
Sponsors
Study design
Eligibility
Inclusion criteria
Age between 2 and 15 years Admitted to the pediatric general inpatient ward Prescribed three or more medications during the hospital stay
Exclusion criteria
Length of hospital stay less than 48 hours Admission to the pediatric intensive care unit (PICU) Estimated life expectancy less than 24 hours
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Medication Errors Identified | From admission to hospital discharge (an average of 3-7 days) | Number of medication errors detected during routine review of inpatient medication orders, including prescribing, dosing, frequency, and administration-related issues. |
Countries
Egypt